Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01827462 · ClinicalTrials.gov registry record · Phase 4
Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 136
- Enrollment target
NCT01827462: Completed Phase 4 study, sponsored by Stanford University.
NCT01827462 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 136 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01827462, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 136 participants
- Enrollment target
Study Summary
In this study the investigators are trying to understand how immune function declines in the elderly using annual influenza vaccinations as a model system. The longitudinal study began in 2007 and continued through early 2017.
Interventions
- BIOLOGICAL Trivalent, inactivated influenza vaccine (TIV)
- BIOLOGICAL Quadrivalent, inactivated influenza vaccine (IIV4)
- BIOLOGICAL High-Dose Trivalent, inactivated influenza vaccine (TIV High-Dose)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2007-10 |
| Est. Completion | 2017-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01827462
The ClinicalTrials.gov registry entry for NCT01827462 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Trivalent, inactivated influenza vaccine (TIV) is the first listed.
NCT01827462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01827462 about?
NCT01827462 is a clinical study titled "Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)". In this study the investigators are trying to understand how immune function declines in the elderly using annual influenza vaccinations as a model system. The longitudinal study began in 2007 and continued through early 2017.
What is the current status of trial NCT01827462?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 136 participants. The study started on 2007-10. Estimated completion is 2017-03.
What interventions are being tested in trial NCT01827462?
The interventions under investigation include: Trivalent, inactivated influenza vaccine (TIV) (BIOLOGICAL), Quadrivalent, inactivated influenza vaccine (IIV4) (BIOLOGICAL), High-Dose Trivalent, inactivated influenza vaccine (TIV High-Dose) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01827462?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.